Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for RAS GTPase
Most Correlated Studies
- Perturbations in Ras/cAMP signal transduction in yeast
- Breast cancer MDA-MB-231 cells treated with RHO GTPase inhibitor DC-RC-063
- Anaplastic thyroid carcinoma 8505c cells expressing SOD3 and cultured in long-term
- Malignant peripheral nerve sheath tumor cells 90-8TL overexpressing SUZ12 or treated with JQ1
- T-ALL cell lines from bone marrow with transduced attenuated KRAS and acquired KRAS mutations
Most Relevant Literature
- Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Irania…
- Leep2A and Leep2B function as a RasGAP complex to regulate macropinosome formation.
- Real-Time Monitoring of RAS Activity Using In Vitro and In-Cell NMR Spectroscopy.
- AIDA-1/ANKS1B Binds to the SynGAP Family RasGAPs with High Affinity and Specificity.
- Non-synaptic function of the autism spectrum disorder-associated gene SYNGAP1 in cortical neurogenes…
Most Relevant Clinical Trials
- Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients
- Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)
- Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
- R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
- PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer
